Bio-chemical angioplasty (BCA), also known as chelation therapy, treats coronary artery disease (CAD). It involves injecting a chemical called ethylenediaminetetraacetic acid (EDTA) into the bloodstream. EDTA binds to calcium, a major component of plaque buildup in the arteries. This helps to break up the plaque and improve blood flow.
BCA typically lasts about an hour over 20-30 treatments. The treatments are usually given over several weeks or months.
BCA is not a standard treatment for CAD, and it needs to be clarified how effective it is. Some studies have shown that it can improve symptoms and reduce the risk of heart attack, but other studies have not found any benefit.
The American Heart Association and the American College of Cardiology do not recommend BCA as a treatment for CAD. However, it can be a helpful alternative to surgery or other medicines.
If you are considering BCA, talking to your doctor about the risks and benefits is essential. They can help you decide if this is the proper treatment for you.
Here are some of the potential risks of BCA:
- Allergic reaction to EDTA
- Low blood pressure
- Headache
- Nausea
- Vomiting
- Muscle cramps
- Pain at the injection site
In rare cases, BCA can cause more serious complications, such as kidney damage or stroke.
If you have any questions or concerns about BCA, be sure to talk to your doctor.
No comments:
Post a Comment